Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00195910 · ClinicalTrials.gov registry record · Phase 2

Safety and Efficacy Study of Hydromorphone and Morphine

A Phase 2 study of Pain, sponsored by Montefiore Medical Center.

Completed
Registry status
Phase 2
Development phase
198
Enrollment target
1
Study location

NCT00195910 is a Phase 2 study of Pain that has completed, run by Montefiore Medical Center. The registered enrollment target is 198 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (35% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00195910, a Phase 2 study of Pain, has completed, sponsored by Montefiore Medical Center.

COMPLETED
Registry status
Phase 2
Development phase
198 participants
Enrollment target
1
Study location

Study Summary

To compare a standard weight-based dose of intravenous (IV) hydromorphone (Dilaudid) to a standard weight-based dose of IV morphine in adults presenting to the Emergency Department (ED) with acute severe pain.

Conditions Studied

Pain

Interventions

  • DRUG Hydromorphone
  • DRUG Morphine

Study Locations (1)

New York

  • Montefiore Medical Center - The Bronx

Trial Details

FieldValue
Enrollment Target 198 participants
Start Date 2004-10
Est. Completion 2005-01
Phase Phase 2

Sponsor

Montefiore Medical Center

345 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00195910

The ClinicalTrials.gov registry entry for NCT00195910 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 198 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (35% lower). The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pain appearing as the primary indexed condition, and to 2 interventions - of which Hydromorphone is the first listed.

NCT00195910 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT00195910 about?

NCT00195910 is a clinical study titled "Safety and Efficacy Study of Hydromorphone and Morphine". To compare a standard weight-based dose of intravenous (IV) hydromorphone (Dilaudid) to a standard weight-based dose of IV morphine in adults presenting to the Emergency Department (ED) with acute severe pain.

What is the current status of trial NCT00195910?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 198 participants. The study started on 2004-10. Estimated completion is 2005-01.

What conditions does trial NCT00195910 study?

This clinical trial studies the following conditions: Pain.

What interventions are being tested in trial NCT00195910?

The interventions under investigation include: Hydromorphone (DRUG), Morphine (DRUG).

Who is sponsoring clinical trial NCT00195910?

This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00195910 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Pain

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.